NICE publishes final draft guidance recommending efanesoctocog alfa as an option for treating and preventing bleeding in people aged 2 and over with severe haemophilia A. These cookies remember ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback